Stay updated on Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.3.3 added, and HHS Vulnerability Disclosure and Revision: v3.3.2 removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated revision history: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved the government funding operating status notice from the page, which previously informed users about potential delays and where to check status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check54 days agoChange DetectedThe record history shows multiple version updates that modify core study details such as study status, recruitment status, arms and interventions, eligibility criteria, and locations.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference12%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.